Alliancebernstein L.P. Kezar Life Sciences, Inc. Transaction History

Alliancebernstein L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.72 - $1.15 $6,192 - $9,890	-8,600 Reduced 9.81%	79,058 $75,000
Q3 2023 Nov 14, 2023	SELL	$1.08 - $2.54 $3,682 - $8,661	-3,410 Reduced 3.74%	87,658 $104,000
Q2 2023 Aug 15, 2023	BUY	$2.31 - $3.06 $54,238 - $71,848	23,480 Added 34.74%	91,068 $223,000
Q4 2022 Feb 14, 2023	BUY	$6.39 - $8.8 $44,091 - $60,720	6,900 Added 11.37%	67,588 $475,000
Q2 2022 Aug 15, 2022	SELL	$4.58 - $17.13 $1.14 Million - $4.26 Million	-248,698 Reduced 80.38%	60,688 $502,000
Q1 2022 May 13, 2022	BUY	$12.3 - $18.33 $2.97 Million - $4.42 Million	241,186 Added 353.65%	309,386 $5.14 Million
Q4 2021 Feb 14, 2022	SELL	$7.44 - $16.72 $70,680 - $158,840	-9,500 Reduced 12.23%	68,200 $1.14 Million
Q2 2021 Jul 30, 2021	BUY	$4.93 - $6.46 $7,395 - $9,690	1,500 Added 1.97%	77,700 $422,000
Q1 2021 May 06, 2021	SELL	$5.24 - $6.99 $8,908 - $11,883	-1,700 Reduced 2.18%	76,200 $454,000
Q2 2020 Aug 13, 2020	BUY	$3.6 - $7.75 $218,880 - $471,200	60,800 Added 355.56%	77,900 $404,000
Q1 2020 May 14, 2020	BUY	$2.77 - $5.75 $17,728 - $36,800	6,400 Added 59.81%	17,100 $75,000
Q2 2019 Aug 14, 2019	BUY	$7.09 - $21.9 $75,863 - $234,329	10,700 New	10,700 $82,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.